Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 2

Status

Not yet recruiting 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Other 3

Conditions

Obesity 9Endometrial Neoplasms 5Prostatic Neoplasms 2Overweight 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Opioid-Related Disorders 1Metabolic Syndrome 1Lymphoma, Follicular 1Insulin Resistance 1Inflammation 1Hyperplasia 1Endometrial Hyperplasia 1Dyslipidemias 1Colorectal Neoplasms 1

Interventions

Paclitaxel 42Carboplatin 35pembrolizumab 25Surveys and Questionnaires 23Letrozole 15Radiotherapy 14Megestrol Acetate 14Blood Specimen Collection 14Bevacizumab 13olaparib 12Metformin 12dostarlimab 10Indocyanine Green 10durvalumab 9Observation 9Medroxyprogesterone Acetate 9Cisplatin 9lenvatinib 8atezolizumab 8Early Intervention, Educational 8Counseling 8niraparib 7Sentinel Lymph Node Biopsy 7Radiation 7Methods 7Magnetic Resonance Spectroscopy 7Lymph Node Excision 7Hysterectomy 7Everolimus 7abemaciclib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Endometrial Neoplasms × Tirzepatide × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07605247 2026-05-22

TREAT-EC

Rutgers, The State University of New Jersey

Phase 2 Not yet recruiting
30 enrolled
Gynecologic

Endometrial Neoplasms

NCT07065552 2026-04-28

Tirzepatide in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

NCT06751589 2026-04-13

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting
36 enrolled
GynecologicOther

Diabetes Mellitus, Obesity, Endometrial Neoplasms, Overweight

NCT06073184 2025-06-10

WE-FiERCE

University Health Network, Toronto

Phase 2 Not yet recruiting
71 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡